Primary Site >> Liver Cancer
Gene >> BHMT
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. PMID: 21878621 |
Ref: A splicing variant leads to complete loss of function of betaine-homocysteine methyltransferase (BHMT) gene in hepatocellular carcinoma. PMID: 22138536 Ref: An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis. PMID: 22434528 |
Ref: Betaine homocysteine methyltransferase (BHMT)-dependent remethylation pathway in human healthy and tumoral liver. PMID: 23449526 Ref: Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. PMID: 23462207 |
Ref: Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas. PMID: 26308133 |
Ref: Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. PMID: 26592251 Ref: Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis. PMID: 27578989 Ref: The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers. PMID: 27936032 |
Ref: Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. PMID: 28238542 Ref: Choline, Other Methyl-Donors and Epigenetics. PMID: 28468239 Ref: One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation. PMID: 28968444 |
Ref: Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice. PMID: 30357543 |